NRL researchers test technology to identify antimicrobial resistance

The U.S. Naval Research Laboratory recently announced on-site testing for its Antimicrobial Resistance Determinant Microarray in conjunction with researchers from the Naval Medical Research Unit II.

The team successfully tested the NRL-developed ARDM at NAMRU-2's satellite laboratory at the National Institutes of Public Health in Phnom Penh, Cambodia. NAMRU-2 studies infectious diseases of critical public health and military importance to the U.S. and partners in the Pacific region.

During the June test, the scientists used the ARDM to test more than 50 drug-resistant pathogens and wound isolates, including methicillin-resistant Staphylococcus aureus. The device simultaneously detects hundreds of pathogens with a one-day turnaround time.

NRL scientist Chris Taitt noted the different types and levels of multi-drug resistance in Phnom Penh in comparison to similar bacterial pathogens from South America, North Africa, West Africa and the Middle East.

Data collected with the ARDM can guide medical personnel toward successful treatment options when dealing with soldiers and sailors deployed to different regions. The knowledge gained may allow epidemiologists to track the spread of new and emerging antibiotic resistance and provide guidance for public health and antimicrobial administration policies to respond quickly to infectious disease outbreaks.

Using the ARDM, researches can more effectively provide the military with knowledge to help protect them against the diseases they might face around the world.